For example, some researchers demonstrated that Pax-5 expression levels correlate with more aggressive forms of astrocytomas [39], neuroendocrine tumors [40], and pulmonary carcinomas [41]. This evidence concerns the gene PAX5 and astrocytoma (excluding glioblastoma).